Fibrogen stock: berger montague investigates potential securities fraud claims against fibrogen, inc. (fgen); lead plaintiff deadline is june 11, 2021

Philadelphia, pennsylvania--(newsfile corp. - may 22, 2021) - berger montague is investigating potential securities fraud claims against fibrogen, inc. ("fibrogen" or the "company"). the firm is investigating these claims on behalf of fibrogen investors who purchased securities (nasdaq: fgen) between october 18, 2017 and april 6, 2021 (the "class period"). if you purchased fibrogen securities, would like to discuss berger montague's investigation, or have questions concerning your rights or interests, please contact attorneys andrew abramowitz...
FGEN Ratings Summary
FGEN Quant Ranking